These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3360275)
1. [Disorders of iron metabolism in hereditary erythrocyte diseases]. Levina AA; Andreeva AP; Nazarli AKh; Kudriavtseva LM; Tsibul'skaia MM Gematol Transfuziol; 1988 Jan; 33(1):11-5. PubMed ID: 3360275 [No Abstract] [Full Text] [Related]
2. Extracorporeal removal of iron with immobilized desferrioxamine. Ambrus CM; Anthone S; Deshpande G; Horvath C; Kalghatgi K ASAIO Trans; 1987; 33(3):749-53. PubMed ID: 3676013 [No Abstract] [Full Text] [Related]
3. [Treatment of thalassemia and sickle cell anemia in children]. Girot R Ann Pediatr (Paris); 1978; 25(5-6):277-84. PubMed ID: 16114336 [No Abstract] [Full Text] [Related]
4. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients. Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137 [TBL] [Abstract][Full Text] [Related]
5. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pakbaz Z; Fischer R; Fung E; Nielsen P; Harmatz P; Vichinsky E Pediatr Blood Cancer; 2007 Sep; 49(3):329-32. PubMed ID: 17554789 [TBL] [Abstract][Full Text] [Related]
6. [Thalassemia trait in the pediatric age and body iron status]. Abreu de Miani MS; Calvo EB; Sanchís ME; Peñalver JA Sangre (Barc); 1986; 31(1):1-6. PubMed ID: 3704880 [No Abstract] [Full Text] [Related]
7. Non-transferrin-bound iron in long-term transfusion in children with congenital anemias. Wang WC; Ahmed N; Hanna M J Pediatr; 1986 Apr; 108(4):552-7. PubMed ID: 3083076 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients. Porter JB; Walter PB; Neumayr LD; Evans P; Bansal S; Garbowski M; Weyhmiller MG; Harmatz PR; Wood JC; Miller JL; Byrnes C; Weiss G; Seifert M; Grosse R; Grabowski D; Schmidt A; Fischer R; Nielsen P; Niemeyer C; Vichinsky E Br J Haematol; 2014 Dec; 167(5):692-6. PubMed ID: 25209728 [TBL] [Abstract][Full Text] [Related]
10. Quantitative studies of ferritinlike iron in erythrocytes of thalassemia, sickle-cell anemia, and hemoglobin Hammersmith with Mössbauer spectroscopy. Bauminger ER; Cohen SG; Ofer S; Rachmilewitz EA Proc Natl Acad Sci U S A; 1979 Feb; 76(2):939-43. PubMed ID: 284419 [TBL] [Abstract][Full Text] [Related]
11. How do I incorporate red cell genotyping to improve chronic transfusion therapy? Van Buren NL; Gorlin JB; Corby SM; Cassidy S; FritchLilla S; Nelson SC; Westhoff CM Transfusion; 2020 Jan; 60(1):16-25. PubMed ID: 31758587 [TBL] [Abstract][Full Text] [Related]
12. Iron status in white sickle cell disease patients. Russo-Mancuso G; Samperi P; Gangarossa S; Consalvo C; Schilirò G Eur J Haematol; 1992 Apr; 48(4):232-3. PubMed ID: 1592104 [No Abstract] [Full Text] [Related]
13. Sickle cell syndromes. II. The sickle cell anemia-alpha-thalassemia syndrome. Honig GR; Koshy M; Mason RG; Vida LN J Pediatr; 1978 Apr; 92(4):556-61. PubMed ID: 633012 [TBL] [Abstract][Full Text] [Related]
14. Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin. Garbowski MW; Evans P; Vlachodimitropoulou E; Hider R; Porter JB Haematologica; 2017 Oct; 102(10):1640-1649. PubMed ID: 28642302 [TBL] [Abstract][Full Text] [Related]
15. Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome. de Montalembert M; Ribeil JA; Brousse V; Guerci-Bresler A; Stamatoullas A; Vannier JP; Dumesnil C; Lahary A; Touati M; Bouabdallah K; Cavazzana M; Chauzit E; Baptiste A; Lefebvre T; Puy H; Elie C; Karim Z; Ernst O; Rose C PLoS One; 2017; 12(3):e0172147. PubMed ID: 28257476 [TBL] [Abstract][Full Text] [Related]
16. Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload. Puliyel M; Sposto R; Berdoukas VA; Hofstra TC; Nord A; Carson S; Wood J; Coates TD Am J Hematol; 2014 Apr; 89(4):391-4. PubMed ID: 24347294 [TBL] [Abstract][Full Text] [Related]
17. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications. Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856 [TBL] [Abstract][Full Text] [Related]